Market Place
Sourcing Support
TScan Therapeutics Reports Q1 2025 Results and Corporate Update
06 May 2025 //
GLOBENEWSWIRE
TScan Refinances Debt with 52.5M Loan from Silicon Valley Bank
23 Dec 2024 //
GLOBENEWSWIRE
TScan Therapeutics Announces Updates to its Board of Directors
14 Jun 2024 //
GLOBENEWSWIRE
TScan At Upcoming Jefferies Healthcare Conference
30 May 2024 //
GLOBENEWSWIRE
TScan Therapeutics Reports Q1 2024 Results, Corporate Update
13 May 2024 //
GLOBENEWSWIRE
TScan to Present at ASCO 2024 Annual Meeting
24 Apr 2024 //
GLOBENEWSWIRE
TScan To Present At ASGCT 2024 Annual Meeting
22 Apr 2024 //
GLOBENEWSWIRE
TScan Therapeutics Announces Closing of Upsized Public Offering
19 Apr 2024 //
GLOBENEWSWIRE
TScan Therapeutics Announces Launch of $125 Million Proposed Public Offering
16 Apr 2024 //
GLOBENEWSWIRE
TScan Therapeutics Announces Pricing of Upsized $150 Million Public Offering
16 Apr 2024 //
GLOBENEWSWIRE
Tscan Appoints Seasoned Hematology and Oncology Expert Louis as CMO
08 Apr 2024 //
GLOBENEWSWIRE
TScan Announces Upcoming Presentation at the Needham Virtual Health Conference
02 Apr 2024 //
GLOBENEWSWIRE
TScan Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results
06 Mar 2024 //
GLOBENEWSWIRE
TScan to Participate in the TD Cowen 44th Annual Health Care Conference
28 Feb 2024 //
GLOBENEWSWIRE
TScan Therapeutics Presents Promising Phase 1 Results on TSC-100 and TSC-101
26 Feb 2024 //
GLOBENEWSWIRE
TScan Therapeutics Appointed Dawn Pinchasik as Vice President
06 Feb 2024 //
GLOBENEWSWIRE
TScan Appoints Seasoned Industry Executive Jason A. Amello as CFO
29 Jan 2024 //
GLOBENEWSWIRE
TScan Therapeutics Announces Best Abstracts Award
18 Jan 2024 //
GLOBENEWSWIRE
TScan Therapeutics Announces 2024 Clinical Plans and Highlights Recent Progress
04 Jan 2024 //
GLOBENEWSWIRE
TScan Therapeutics Appoints R. Keith Woods to its Board of Directors
07 Dec 2023 //
GLOBENEWSWIRE
TScan Therapeutics Appointed Justin McCue, Ph.D., as Chief Technology Officer
04 Dec 2023 //
GLOBENEWSWIRE
TScan Therapeutics to Host Virtual KOL Event
04 Dec 2023 //
GLOBENEWSWIRE
TScan Therapeutics Reports Third Quarter 2023 Financial Results
09 Nov 2023 //
GLOBENEWSWIRE
TScan Therapeutics Presents Phase 1 Trial Design for Solid Tumor Program
06 Nov 2023 //
GLOBENEWSWIRE
TScan Therapeutics Announces Upcoming Presentation at the 65th Annual Meeting
02 Nov 2023 //
GLOBENEWSWIRE
TScan Therapeutics Announces Upcoming Presentations at Annual Meeting
27 Sep 2023 //
GLOBENEWSWIRE
TScan Therapeutics to Participate in Upcoming Investor Conferences
05 Sep 2023 //
GLOBENEWSWIRE
Tscan Announces FDA Clearance of Invg NDA for TSC-203-A0201 Targeting PRAME
29 Aug 2023 //
GLOBENEWSWIRE
TScan Therapeutics Reports Second Quarter 2023 Financial Results
10 Aug 2023 //
GLOBENEWSWIRE
Longwood launches startup Solu with drug candidates from GSK and $31M to start
01 Aug 2023 //
ENDPTS
TScan Therapeutics Announces Transition of Chief Financial Officer
29 Jun 2023 //
GLOBENEWSWIRE
TScan Announces FDA Clearance of Investigational NDA for TSC-200-A0201
06 Jun 2023 //
GLOBENEWSWIRE
TScan Therapeutics to Participate in the Jefferies Healthcare Conference
01 Jun 2023 //
GLOBENEWSWIRE
TScan Therapeutics Announces Pricing of $140 Million Public Offering
26 May 2023 //
GLOBENEWSWIRE
TScan Therapeutics Announces Launch of Proposed Public Offering
25 May 2023 //
GLOBENEWSWIRE
TScan Appoints Gavin MacBeath, Ph.D. as CEO and as a Member of the BOD
24 May 2023 //
GLOBENEWSWIRE
TScan Therapeutics Reports 1Q 2023FYR &Provides Corporate Update
10 May 2023 //
GLOBENEWSWIRE
TScan Therapeutics Announces CEO Transition
31 Mar 2023 //
GLOBENEWSWIRE
TCR upstart announces CEO exit, with CSO now acting replacement
31 Mar 2023 //
ENDPTS
TScan Therapeutics to Participate in the Barclays Global Healthcare Conference
13 Mar 2023 //
GLOBENEWSWIRE
TScan Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results
08 Mar 2023 //
GLOBENEWSWIRE
TScan Therapeutics to Participate in Cowen 43rd Annual Health Care Conference
01 Mar 2023 //
GLOBENEWSWIRE
TScan Announces Presentation at H.C. Wainwright Cell Therapy Virtual Conference
21 Feb 2023 //
GLOBENEWSWIRE
TScan Announces FDA Clearance of NDA for the Treatment of Solid Tumors
23 Jan 2023 //
GLOBENEWSWIRE
TScan Therapeutics Announces 2023 Clinical Plans and Highlights Recent Progress
05 Jan 2023 //
GLOBENEWSWIRE
TScan Therapeutics Presents Phase 1 Umbrella Trial in Progress on HA-1
12 Dec 2022 //
GLOBENEWSWIRE
TScan Named the Highest-Placed Midsize Biotechnology Company in The Top Places
01 Dec 2022 //
GLOBENEWSWIRE
TScan to Participate in the 5th Annual Evercore ISI HealthCONx Conference
22 Nov 2022 //
GLOBENEWSWIRE
TScan Therapeutics Presents Preclinical Data for Solid Tumor Program at the SITC
11 Nov 2022 //
GLOBENEWSWIRE
TScan Announces Upcoming Poster Presentation at the 64th American Society
03 Nov 2022 //
GLOBENEWSWIRE
TScan Therapeutics Announces Upcoming Poster Presentations at the 37th Society
05 Oct 2022 //
GLOBENEWSWIRE
TScan Therapeutics to Participate in Upcoming Investor Conferences
22 Sep 2022 //
GLOBENEWSWIRE
TScan Therapeutics Secures Convertible Debt Facility for up to $60 M
12 Sep 2022 //
GLOBENEWSWIRE
TScan Therapeutics to Participate in the Morgan Stanley 20th Annual GHC
07 Sep 2022 //
GLOBENEWSWIRE
TScan Therapeutics Reports Q2 Financial Results and Highlights Recent Progress
10 Aug 2022 //
GLOBENEWSWIRE
TScan Therapeutics to Participate in the 13th Annual Wedbush Conference
03 Aug 2022 //
GLOBENEWSWIRE
TScan Tx publishes Cell Highlighting the Discovery of Tumor Antigens and TCRs
11 Jul 2022 //
GLOBENEWSWIRE
TScan Therapeutics Appoints Debora Barton, M.D., as Chief Medical Officer
07 Jul 2022 //
GLOBENEWSWIRE
TScan Tx to Participate in the LifeSci 2nd Annual Genetic Medicines Symposium
22 Jun 2022 //
GLOBENEWSWIRE
